Selected acute phase CSF factors in ischemic stroke: Findings and prognostic value

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Beridze, Maia ^a   Sanikidze, Tamar ^a   Shakarishvili, Roman ^a   Intskirveli, Nino ^a   Bornstein, Natan M ^b  

^a TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

brainischemiainflammation; oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; LIPID PEROXIDE; NITRIC OXIDE; REAGENT; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER;

AGED; ARTICLE; BLOOD LEVEL; BRAIN ISCHEMIA; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON SPIN RESONANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROGNOSIS; RELIABILITY; SCORING SYSTEM; CEREBROSPINAL FLUID; MIDDLE AGED; PATHOLOGY; STROKE;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE;

EID: 79953091939     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-41     Document Type: Article

References (28)

1. Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F. Neuronal damage in brain inflammation. Arch Neurol 2007, 64(2):185-189. 10.1001/archneur.64.2.185, 17296833.
2. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Rad Biol Med 2005, 39:841-852. 10.1016/j.freeradbiomed.2005.06.025, 16140205.
3. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. Cerebrovasc Dis 2008, 25:457-507. 10.1159/000131083, 18477843, The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee.
4. Adams HP, Bendixen BH, Kapelle LJ, . the TOAST investigators Classification of subtypes of acute ischemic stroke. Definitions for use of multicenter clinical trial TOAST. Stroke 1993, 24:35-41. the TOAST investigators.
5. Jood K, Redfors P, Rosengren A, Blomstrand CH, Jern CH. Self-perceived psychological stress and ischemic stroke: a case-control study. BMC Medicine 2009, 7:53. 10.1186/1741-7015-7-53, 2761941, 19796376.
6. Truelsen T, Nielsen N, Boysen G, Grønbæk M. Self-Reported Stress and Risk of Stroke, The Copenhagen City Heart Study. Stroke 2003, 34:856-862. 10.1161/01.STR.0000062345.80774.40, 12637696.
7. Adams HP, et al. NIHSS and Patient Outcomes. Neurology 1999, 53:126-131.
8. Dromerick AW, Edwards DF, Diringer MN. Sensitivity to changes in disability after stroke: A comparison of four Scales useful in clinical trials. Journal of Rehabilitation Research and Development 2003, 40(1):1-8. 10.1682/JRRD.2003.01.0001, 15150715.
9. Govan L, Langhorne P, Weir CJ. Categorizing stroke prognosis using different stroke scales. Stroke 2009, 40(10):3396-9. 10.1161/STROKEAHA.109.557645, 19661471.
10. Fink B, Fink N. EPR techniques for detection of nitric oxide in vivo as an index of endothelial disfunction. Pharmacological reports 2006, 58:8-15.
11. Richardson RS, Donato AJ, Uberoi AD, Wray W, Lawrenson L, Nishiyama S, Bailey DM. Exercise-induced brachial artery vasodilation: role of free radicals. Am JPhysiol Heart Circ Physiol 2007, 292:1516-1522.
12. Guevara I, Iwanejko J, Dembinska-Kiec A, et al. Determination of nitrite/nitrate in human biological material by the sample Griess reaction. Clin Chim Acta 1998, 274:177-88. 10.1016/S0009-8981(98)00060-6, 9694586.
13. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 1994, (55):195-203. 10.1016/0165-5728(94)90010-8, 7530260.
14. Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines on the serum of patients with acute cerebral ischemia, kinetics and secretion and relation to the extent of brain damage and outcome of disease. J neurol Sci 1994, 122:135-139. 10.1016/0022-510X(94)90289-5, 8021695.
15. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995, 147:1477-1486. 1869513, 7485410.
16. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006, 37:291-293. 10.1161/01.STR.0000200561.69611.f8, 1852506, 16410468.
17. Smith CJ, Emsley HCA, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume. stroke severity, and long-term outcome. BMC Neurol 2004, 4:2-9. 10.1186/1471-2377-4-2, 331413, 14725719.
18. Emsley HCA, Smith CJ, Georgiou RF, Vail A, Tyrrell P-J, Barberen E-M, et al. Correlation of systemic inflammatory response with infarct volume in acute ischemic patients Response. Stroke 2005, 36(2):228-229.
19. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-a a mediator of focal ischemic brain injury. Stroke 1997, 28:1233-1244.
20. Martin-Villaba A, Herr I, Jeremias I, et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999, 19:3809-3817.
21. Dietrich ND, Busto R, Bethea JR. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol 1999, 158:444-450. 10.1006/exnr.1999.7115, 10415151.
22. Spera PA, Ellison JA, Feurstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251:189-192. 24, 10.1016/S0304-3940(98)00537-0, 9726375.
23. Chong WL, Sengupta A, Sandercock P. Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review. Stroke 2009, 40:380-389.
24. Kunz A, Park L, Abe T, Gallo EF, Anrather J, Zhou P, Iadecola C. Neurovascular protection by ischemic tolerance: Role of Nitric Oxide and Reactive Oxygen Species. J Neurosci 2007, 27(27):7083-7093. 10.1523/JNEUROSCI.1645-07.2007, 17611261.
25. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, (329:):2002-2012.
26. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991, 41:485-490. 10.1016/0006-2952(91)90618-F, 1847633.
27. Orio D, Kunz A, Kawano T, Anrather J, Zhou P, Iadecola C. Lipopolysaccharide Induces Early Tolerance to Excitotoxicity via Nitric Oxide and cGMP. Stroke 2007, 38(10):2812-2817. 10.1161/STROKEAHA.107.486837, 17761917.
28. Lavi SH, Egbarya R, Lavi R, Jacob G. Role of Nitric Oxide in the Regulation of Cerebral Blood Flow in Humans. Circulation 2003, 107:1901. 10.1161/01.CIR.0000057973.99140.5A, 12665500.